SureTrader SureTrader
Home > Boards > Canadian > Medical - Drugs >

Syndax Pharmaceuticals Inc (SNDX)

Add SNDX Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 3/24/2016 9:13:34 PM - Followers: 2 - Board type: Free - Posts Today: 0
Syndax Pharmaceuticals, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on the development of entinostat as a combination therapy in multiple cancer indications with a focus on tumors that are sensitive to immunotherapy, including lung cancer, melanoma, ovarian cancer and triple-negative breast cancer (TNBC). The Company is also developing Entinostat as a combination therapeutic in a Phase III clinical trial, which is being conducted with ECOG-ACRIN for advanced hormone receptor positive (HR+) breast cancer. The Company's Entinostat is an oral, small molecule histone deacetylase (HDAC) inhibitor that has direct effects on both cancer cells and immune regulatory cells, and also enhances the body’s immune response to tumors. The Company's product pipeline for immune-oncology includes ENCORE 601, ENCORE 602, ENCORE 603, J1353, NCI-7870 and NCI-9844. Its pipeline for advanced HR+ breast cancer includes E2112.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
SNDX News: Amended Current Report Filing (8-k/a) 10/07/2016 04:26:14 PM
SNDX News: Confidential Treatment Order (ct Order) 10/06/2016 02:26:59 PM
SNDX News: Schedule 13g 09/12/2016 10:48:50 AM
SNDX News: Syndax Pharmaceuticals Announces Participation at Four Upcoming Investor Conferences  09/06/2016 07:00:00 AM
SNDX News: Syndax Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update 08/09/2016 06:30:00 AM
#3   I got this on my radar. I love the Minuteman-MX 03/24/16 09:13:34 PM
#2 T695 03/10/16 05:35:19 PM
#1   SNDX had a nice pull back today abs T695 03/10/16 05:31:07 PM